ArticleNPJ precision oncology2026
Graph neural network modeling of spatial tumor-immune interactions identifies prognostic cellular niches in non‑small cell lung cancer.
Article in NPJ precision oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Deciphering immunosuppressive niches by spatial single-cell proteomics: spatial interaction networks and translational opportunities.Frontiers in immunology · 2026Review
- Formation and remodeling of immunological niches in solid tumors: organ-specific architectures, inflammatory parallels, and therapeutic reprogramming.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The spatial organization of immune and tumor cells within the tumor microenvironment (TME) has a critical influence on antitumor immunity and patient survival. However, hand-engineered metrics such as cell densities or pairwise proximity scores fail to capture the complexity of local cell-cell interactions. Understanding these higher-order spatial patterns and their relation to patient outcomes is especially important for non-small cell lung cancer (NSCLC), the deadliest cancer worldwide. Here, we elucidate the NSCLC TME using a graph neural network (GNN)-based framework to model spatially localized cellular neighborhoods in multiplex immunofluorescence data from a clinical cohort of 506 patients. The GNN predicted patient survival with high accuracy (concordance index: 0.82) and remained a significant prognostic factor when adjusted for clinical covariates. Interpretability analyses revealed that specific combinations of cell types, particularly involving CD8+ T cells, PD-L1+ immune cells, and FOXP3+ regulatory T cells, modulated predictions depending on their spatial context. In-silico manipulation experiments applied to the trained GNN, used here as an interpretable surrogate model, suggested that the impact of CD8+ cells on survival were estimated as favorable when in direct tumor contact and less favorable when adjacent to immunosuppressive cells. Latent-space clustering identified distinct TME states predictive of outcome, reflecting varying balances of immune activation and evasion. Our approach underscores the prognostic significance of spatially resolved immune-tumor interactions, providing a blueprint for developing next-generation spatial biomarkers to guide precision treatment strategies in NSCLC.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.